Vardenafil Hydrochloride oral soluble Pellicles(Qilu Pharma)

盐酸伐地那非口溶膜(齐鲁制药)

Report date: 2025/07/23 15:39:28

Base Information

Drug NameVardenafil Hydrochloride oral soluble Pellicles(Qilu Pharma)
Drug Alias NameNuviva瓦地拉非盐酸盐Vardenafilum伐地那非
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A